JFG
RVMD icon

Jefferies Financial Group’s Revolution Medicines RVMD Stock Holding History

Jefferies Financial Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,490
Closed -$242K – 2000
2026
Q1 		$242K Sell
2,490
-1,138,705
-100% -$115M ﹤0.01% 1446
2025
Q4 		$90.9M Buy
1,141,195
+1,128,195
+8,678% +$74M 0.46% 32
2025
Q3 		$607K Sell
13,000
-2,788
-18% -$109K ﹤0.01% 1020
2025
Q2 		$581K Sell
15,788
-147,509
-90% -$5.67M ﹤0.01% 867
2025
Q1 		$5.77M Buy
163,297
+140,572
+619% +$5.71M 0.05% 256
2024
Q4 		$994K Buy
+22,725
New +$1.15M 0.01% 884
2024
Q2 		– Sell
-30,422
Closed -$981K – 1819
2024
Q1 		$981K Sell
30,422
-42,932
-59% -$1.27M 0.01% 834
2023
Q4 		$2.1M Buy
+73,354
New +$1.76M 0.01% 694

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jefferies Financial Group's RVMD Position: Q2 2026 in Review

Jefferies Financial Group sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 2,490 shares — an estimated $242K sold.

Jefferies Financial Group first reported a position in RVMD in Q4 2023 and held it in 8 quarters. The position peaked at $90.9M in Q4 2025. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Jefferies Financial Group reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 2,490 Revolution Medicines shares in Q2 2026, an estimated $242K.
  • Jefferies Financial Group first reported a position in Revolution Medicines in Q4 2023 and held it in 8 quarters.
  • Jefferies Financial Group's Revolution Medicines position peaked at $90.9M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.